PARP inhibitors

0:03:12

How PARP inhibitors (PARPi) work

0:04:12

PARP Inhibitors

0:03:05

An Overview of PARP Inhibitors in Ovarian Cancer

0:59:14

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

0:03:12

PARP-inhibitors: A New Generation of Cancer Drugs

0:02:47

What is a PARP Inhibitor? | Dana-Farber Cancer Institute | Science Illustrated

0:12:11

PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci

0:12:24

The Role of Targeting DNA Repair with PARP

0:01:43

PARP Inhibitors for Prostate Cancer

0:01:26

PARP Inhibitors for Maintenance Therapy in Ovarian Cancer

0:06:35

PARP Inhibitor Side Effect Management in Ovarian Cancer

0:03:45

PARP inhibitors for ovarian cancer

0:02:38

Seminar Clips: PARP Inhibitors and BRRCA1/2 Cancers- Susan Domchek, MD | Stanford Cancer Institute

0:58:44

What’s New with PARP Inhibitors and Ovarian Cancer?

0:01:22

Overcoming resistance to PARP inhibition in ovarian cancer

0:06:22

Do I Need PARP Inhibitors To Treat My Breast Cancer? What to Expect, Eligibility, and Side Effects

0:01:01

Choosing the correct PARP inhibitor for prostate cancer

0:01:27

PARP Inhibition Improves Outcomes in Patients With BRCA-Mutated Ovarian Cancer

0:05:53

Adverse-Effect Profiles of PARP Inhibitors in Ovarian Cancer

0:01:38

Updates in PARP inhibition for ovarian cancer

0:06:40

Ovarian Cancer: How PARP Inhibitors Work

1:27:23

The Role of PARP Inhibitors in Advanced Prostate Cancer (2023)

0:03:58

BRCA+ Breast Cancer: The Advent of PARP Inhibitors

0:00:31

Which mutations benefit most from PARP inhibitors in prostate cancer?